This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Archived

This page has been archived on the Web.

Health product recall

Sambucol Cold & Flu (2015-10-08)

Starting date:
October 8, 2015
Posting date:
October 13, 2015
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type II
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-55324

Affected Products

Sambucol Cold & Flu

Reason

Contraindication for people allergic to acetylsalicylic acid or other salicylates not stated on product label.

Depth of distribution

Wholesalers and retailers. (BC, AB, SK, MB, ON, QC, NB, NS, NF)

Affected products

Sambucol Cold & Flu

DIN, NPN, DIN-HIM
NPN 80060823
Dosage form

Capsule

Strength

Echinacea purpurea - 44.5mg
Salix alba - 77.4mg (15.5:1)
Sambucus nigra subsp. nigra - 30mg (50:1)
Vitamin C - 245mg
Zinc - 12mg

Lot or serial number

60048811

Companies
Recalling Firm
Associated National Brokerage Inc. (ANB)
199 Mathew Boyd Cres.
Newmarket
L3X 3C7
Ontario
CANADA
Marketing Authorization Holder
PAC Health (Canada) Inc.
1235 Bay St., Suite 400 Toronto ON M5R 3K4
Toronto
M5R 3K4
Ontario
CANADA

Date modified: